5% 5-Fluorouracil cream for treatment of verruca vulgaris in children

Pediatric Dermatology

Volumn 26, Issue 3, 2009, Pages 279-285

  Gladsjo, Julie Akiko ^b   Alió Sáenz, Alessandra B ^c   Bergman, James ^d   Kricorian, Greg ^e   Cunningham, Bari B ^a  

^a 477 N EI Camino Real G 204 ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e Valeant Pharmaceuticals International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CIMETIDINE; FLUOROURACIL; LIQUID NITROGEN; SALICYLIC ACID;

ADOLESCENT; ADULT; ARTICLE; BLOOD CELL COUNT; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DISEASE DURATION; DOSAGE SCHEDULE COMPARISON; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EROSION; ERYTHEMA; EVENING DOSAGE; FEMALE; FOLLOW UP; HAND; HUMAN; HYPERKERATOSIS; HYPERPIGMENTATION; LIVER FUNCTION TEST; MALE; MORNING DOSAGE; OPEN STUDY; PATIENT SATISFACTION; PILOT STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SCHOOL CHILD; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VERRUCA VULGARIS;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ANTIMETABOLITES; CHILD; CHILD, PRESCHOOL; FLUOROURACIL; HAND DERMATOSES; HUMANS; OINTMENTS; WARTS;

EID: 67650492920     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2008.00800.x     Document Type: Article

References (24)

1. Sterling JC, Kurtz JB. Human papilloma virus. In : Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook's textbook of dermatology, 7th ed, Vol. 2. Malden, Massachusetts : Blackwell Science Ltd., 2004 : 25.37 25.55.
2. Williams HC, Pottier A, Strachan D. The descriptive epidemiology of warts in British school children. Br J Dermatol 1993 128 : 504 511. (Pubitemid 23155946)
3. Kilkenny M, Merlin K, Marks R. The prevalence of common skin conditions in Australian school students: 1. Common plane and plantar viral warts. Br J Dermatol 1998 138 : 840 845.
4. Massing AM, Epstein WL. Natural history of warts: a two year study. Arch Dermatol 1963 87 : 306 310.
5. Rubben A, Kalka K, Spelten B et al. Clinical features and age distribution in patients with HPV 2/27/57-induced common warts. Arch Dermatol Res 1997 289 : 337 340. (Pubitemid 27272014)
6. Drake LA, Ceilley RI, Cornelison RL et al. Guidelines of care for warts: human papillomavirus. J Am Acad Dermatol 1995 32 : 98 103.
7. Gibbs S, Harvey I. Topical treatment for cutaneous warts. Cochrane Database Syst Rev 2006 Jul 19:3.
8. Torrelo A. What's new in the treatment of viral warts in children. Pediatr Dermatol 2002 19 : 191 199. (Pubitemid 34625776)
9. Senff H, Reindel D, Matthies C et al. Topical 5-fluorouracil solution in the treatment of warts - clinical experience and percutaneous absorption. Br J Dermatol 1988 118 : 409 414. (Pubitemid 18157491)
10. Levy S, Furst K, Chern W. A pharmacokinetic evaluation of 0.5% and 5% 5-fluorouracil topical cream in patients with actinic keratosis. Clin Ther 2001 23 : 908 920. (Pubitemid 32554572)
11. Beutner KR, Ferenczy A. Therapeutic approaches to genital warts. Am J Med 1997 102 : 28 37. (Pubitemid 127695957)
12. Clayton AS, Stasko T. Treatment of nonmelanoma skin cancer in organ transplant recipients: review of responses to a survey. J Am Acad Dermatol 2003 49 : 413 416. (Pubitemid 37051902)
13. Hursthouse M. Treatment of warts with 5-fluorouracil. Br J Dermatol 1970 83 : 218.
14. Hursthouse M. A controlled trial on the use of topical 5-fluoruracil on viral warts. Br J Dermatol 1975 92 : 93 96.
15. Lee S, Kim J-G, Chun SI. Treatment of verruca plana with 5% 5-fluorouracil ointment. Dermatologica 1980 160 : 383 389. (Pubitemid 10149289)
16. Salk R, Grogan K, Kricorian G et al. A randomized, controlled trial of 5% 5-fluorouracil cream under tape occlusion versus tape occlusion alone in the treatment of foot warts. Presentation at the American Academy of Dermatology Summer Meeting, 2004 July 29-Aug 1, New York, NY.
17. Miller E. The metabolism and pharmacology of 5-fluorouracil. J Surg Oncol 1971 3 : 309 315.
18. Casale F, Canaparo R, Serpe L et al. Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients. Pharmacol Res 2004 50 : 173 179. (Pubitemid 38737249)
19. Gamelin E, Boisdron-Celle M, Delva R, Regimbeau C et al. Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimatization by pharmacokinetic monitoring in 152 patients. J Clin Oncol 1998 16 : 1470 1478. (Pubitemid 28175768)
20. 14C-5-fluorouracil ointment applied in an ointment to healthy and diseased human skin. Dermatologica 1970 140 (Suppl. 1 7 14.
21. Jeffes EWB, Chen JT. New approaches to the treatment of actinic keratosis. Am J Cancer 2003 2 : 151 168. (Pubitemid 36876614)
22. Focht DR, Spicer C, Fairchok MP. The efficacy of duct tape vs. cryotherapy in the treatment of verruca vulgaris (the common wart). Arch Pediatr Adolesc Med 2002 156 : 971 974. (Pubitemid 36343471)
23. Johnson MR, Hageboutros A, Wang K et al. Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil. Clin Cancer Res 1999 5 : 2006 2011. (Pubitemid 29399251)
24. Heggie GD, Sommadossi J-P, Cross DS et al. Clinical pharmacokinetics of 5-fluorouracil and its metabolism in plasma, urine, and bile. Cancer Res 1987 47 : 2203 2206. (Pubitemid 17074634)